PET in oncology I - lung, breast, soft tissue sarcoma

被引：11

作者：

O'Doherty, MJ ^{[1
]}

机构：

[1] Guys & St Thomas Hosp, Clin PET Ctr, London SE1 9RT, England

来源：

NUCLEAR MEDICINE COMMUNICATIONS | 2000年 / 21卷 / 03期

关键词：

D O I：

10.1097/00006231-200003000-00004

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

[No abstract available]

引用

页码：224 / 229

页数：6

共 47 条

[1]

ADLER LP, 1991, J NUCL MED, V32, P1508

[2] GRADING LIPOSARCOMAS WITH PET USING [F-18] FDG [J].

ADLER, LP ;

BLAIR, HF ;

WILLIAMS, RP ;

PATHRIA, MN ;

MAKLEY, JT ;

JOYCE, MJ ;

ALKAISI, N ;

MIRALDI, F .

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1990, 14 (06) :960-962

[3]

Ahuja V, 1998, CANCER, V83, P918, DOI 10.1002/(SICI)1097-0142(19980901)83:5<918::AID-CNCR17>3.3.CO

[4]

2-#

[5] Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)fluoro-2-deoxy-D-glucose [J].

Avril, N ;

Dose, J ;

Janicke, F ;

Ziegler, S ;

Romer, W ;

Weber, W ;

Herz, M ;

Nathrath, W ;

Graeff, H ;

Schwaiger, M .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (17) :1204-1209

[6]

Bakheet SM, 1998, SEMIN NUCL MED, V28, P352

[7] Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer [J].

Boerner, AR ;

Weckesser, M ;

Herzog, H ;

Schmitz, T ;

Audretsch, W ;

Nitz, U ;

Bender, HG ;

Mueller-Gaertner, HW .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (03) :226-230

[8] INDETERMINATE ADRENAL MASS IN PATIENTS WITH CANCER - EVALUATION AT PET WITH 2-[F-18]-FLUORO-2-DEOXY-D-GLUCOSE [J].

BOLAND, GW ;

GOLDBERG, MA ;

LEE, MJ ;

MAYOSMITH, WW ;

DIXON, J ;

MCNICHOLAS, MM ;

MUELLER, PR .

RADIOLOGY, 1995, 194 (01) :131-134

[9] Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer [J].

Bury, T ;

Dowlati, A ;

Paulus, P ;

Corhay, JL ;

Hustinx, R ;

Ghaye, B ;

Radermecker, M ;

Rigo, P .

EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (11) :2529-2534

[10]

Calman K., 1995, POLICY FRAMEWORK COM

← 1 2 3 4 5 →